TET2 and acute myeloid leukemia: Concurrent TET2 and EZH2 deletion is sufficient to induce an MDS/myeloproliferative phenotype in mice [62], and in a RUNX1 mutant model, EZH2 loss promotes myelodysplasia development but inhibits transformation to AML [63].